1 Based on the low incidence of thromboembolic complications in asymptomatic patients, the high
cost of routine DUS, the futility of performing randomized trials evaluating the utility of routine DUS, and

recommendations against screening in other higherrisk populations, we recommend against routine ultrasound surveillance following saphenous vein ablation in
low or average risk patients for thrombotic complications
Although evidence in randomized trials of routine ultrasound screening is lacking, the strength of our recommendation is 